Lung cancer survival among never smokers.

Humans Lung Neoplasms / epidemiology SEER Program Survival Analysis Tobacco Smoking
Lung neoplasms Never smokers Survival

Journal

Cancer letters
ISSN: 1872-7980
Titre abrégé: Cancer Lett
Pays: Ireland
ID NLM: 7600053

Informations de publication

Date de publication:
01 06 2019
Historique:
received: 26 10 2018
revised: 13 02 2019
accepted: 28 02 2019
pubmed: 10 3 2019
medline: 15 2 2020
entrez: 10 3 2019
Statut: ppublish

Résumé

Lung cancer incidence among never smokers has increased in recent decades with 10-30% of all lung cancers occurring in never smokers, where exposure to residential radon is the leading cause of this disease. Lung cancer survival is low, ranging from 12% to 16% at 5 years of diagnosis. There is scant evidence to date on survival from this disease in never smokers. We aim to evaluate lung cancer survival in never smokers and ascertain whether there might be differences regarding smokers, through a systematic review applying predefined inclusion and exclusion criteria. 17 Studies were included. Never-smoker lung cancer patients seem to experience longer survival times than do smokers or ex-smokers. Lung cancer in never smokers displays distinctive clinical characteristics, is more frequent among women, is diagnosed at more advanced stages, and the predominant histologic type is adenocarcinoma. Further studies are necessary to ascertain lung cancer survival among never smokers.

Identifiants

DOI: 10.1016/j.canlet.2019.02.047 PMID: 30851418
pubmed: 30851418
pii: S0304-3835(19)30133-8
doi: 10.1016/j.canlet.2019.02.047
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

142-149

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Ana Casal-Mouriño (A)

Neumology Department, Santiago de Compostable University Teaching Hospital, Spain; Department of Preventive Medicine and Public Health, School of Medicine, University of Santiago de Compostela, Spain.

Luis Valdés (L)

Neumology Department, Santiago de Compostable University Teaching Hospital, Spain; Interdisciplinary Neumology Research Group, Health Research Institute of Santiago de Compostela (Instituto Investigación Sanitaria de Santiago de Compostela/IDIS), Spain.

Juan Miguel Barros-Dios (JM)

Department of Preventive Medicine and Public Health, School of Medicine, University of Santiago de Compostela, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBER en Epidemiología y Salud Pública /CIBERESP), Spain.

Alberto Ruano-Ravina (A)

Department of Preventive Medicine and Public Health, School of Medicine, University of Santiago de Compostela, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBER en Epidemiología y Salud Pública /CIBERESP), Spain; Department of Epidemiology, Brown School of Public Health, Brown University, Providence, Rhode Island, USA. Electronic address: alberto.ruano@usc.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Lung cancer survival among never smokers.
questionsmedicales.fr › Maladies de l'appareil respiratoire › Tumeurs de l'appareil respiratoire › Tumeurs du poumon › Lung cancer survival among never smokers.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enregistrements › Programme SEER › Lung cancer survival among never smokers.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Analyse de survie › Lung cancer survival among never smokers.
questionsmedicales.fr › Comportement et mécanismes comportementaux › Comportement › Usage de tabac › Fumer du tabac › Lung cancer survival among never smokers.